Patellar resurfacing in total knee replacement: five-year clinical and economic results of a large randomized controlled trial

KAT Trial Group

Research output: Contribution to journalArticle

54 Citations (Scopus)
1 Downloads (Pure)

Abstract

Background:
There is conflicting evidence regarding the merits of patellar resurfacing during total knee arthroplasty, as many of the previous randomized controlled trials have not been adequately powered.

Methods:
A pragmatic, multicenter, randomized controlled trial was initiated in 1999 in the United Kingdom. Within a partial factorial design, 1715 patients were randomly allocated to receive or not receive patellar resurfacing during total knee arthroplasty. The primary outcome measure was the Oxford Knee Score; secondary measures included the Short Form-12, the EuroQoL 5D, cost, cost-effectiveness, and the need for subsequent knee surgery.

Results:
The mean Oxford Knee Score was 35 points at five years postoperatively in both groups. There was no significant difference between the groups with respect to the mean Oxford Knee Score (difference, 0.59 point; 95% confidence interval, –0.58 to 1.76 points) or any other outcome measure at five years postoperatively. The outcome was not affected by whether the patella was domed or anatomic. There was no significant difference between the two groups with respect to the prevalence of knee-related readmission, of minor or intermediate reoperation, or of subsequent patella-related surgery. The total health care cost for the primary arthroplasty, subsequent monitoring, and any revision surgery did not differ significantly between the two groups.

Conclusions:
In the largest randomized controlled trial of patellar resurfacing reported to date, the functional outcome, reoperation rate, and total health care cost five years after primary total knee arthroplasty were not significantly affected by the addition of patellar resurfacing to the surgical procedure.

Level of Evidence:
Therapeutic Level I. See Instructions to Authors for a complete description of levels of evidence.
Original languageEnglish
Pages (from-to)1473-1481
Number of pages9
JournalThe Journal of Bone & Joint Surgery. American Volume
Volume93
Issue number16
DOIs
Publication statusPublished - 17 Aug 2011

Fingerprint

Knee Replacement Arthroplasties
Knee
Randomized Controlled Trials
Economics
Reoperation
Patella
Health Care Costs
Outcome Assessment (Health Care)
Arthroplasty
Cost-Benefit Analysis
Confidence Intervals
Costs and Cost Analysis

Cite this

Patellar resurfacing in total knee replacement : five-year clinical and economic results of a large randomized controlled trial. / KAT Trial Group.

In: The Journal of Bone & Joint Surgery. American Volume, Vol. 93, No. 16, 17.08.2011, p. 1473-1481.

Research output: Contribution to journalArticle

@article{8b627dc8b57c4e4d8df8dff46a90cc52,
title = "Patellar resurfacing in total knee replacement: five-year clinical and economic results of a large randomized controlled trial",
abstract = "Background: There is conflicting evidence regarding the merits of patellar resurfacing during total knee arthroplasty, as many of the previous randomized controlled trials have not been adequately powered.Methods: A pragmatic, multicenter, randomized controlled trial was initiated in 1999 in the United Kingdom. Within a partial factorial design, 1715 patients were randomly allocated to receive or not receive patellar resurfacing during total knee arthroplasty. The primary outcome measure was the Oxford Knee Score; secondary measures included the Short Form-12, the EuroQoL 5D, cost, cost-effectiveness, and the need for subsequent knee surgery.Results: The mean Oxford Knee Score was 35 points at five years postoperatively in both groups. There was no significant difference between the groups with respect to the mean Oxford Knee Score (difference, 0.59 point; 95{\%} confidence interval, –0.58 to 1.76 points) or any other outcome measure at five years postoperatively. The outcome was not affected by whether the patella was domed or anatomic. There was no significant difference between the two groups with respect to the prevalence of knee-related readmission, of minor or intermediate reoperation, or of subsequent patella-related surgery. The total health care cost for the primary arthroplasty, subsequent monitoring, and any revision surgery did not differ significantly between the two groups.Conclusions: In the largest randomized controlled trial of patellar resurfacing reported to date, the functional outcome, reoperation rate, and total health care cost five years after primary total knee arthroplasty were not significantly affected by the addition of patellar resurfacing to the surgical procedure.Level of Evidence: Therapeutic Level I. See Instructions to Authors for a complete description of levels of evidence.",
author = "Suzanne Breeman and Marion Campbell and Helen Dakin and Nick Fiddian and Ray Fitzpatrick and Adrian Grant and Alastair Gray and Linda Johnston and Graeme Maclennan and Richard Morris and David Murray and {KAT Trial Group}",
year = "2011",
month = "8",
day = "17",
doi = "10.2106/JBJS.J.00725",
language = "English",
volume = "93",
pages = "1473--1481",
journal = "The Journal of Bone & Joint Surgery. American Volume",
issn = "0021-9355",
publisher = "Journal of Bone and Joint Surgery Inc.",
number = "16",

}

TY - JOUR

T1 - Patellar resurfacing in total knee replacement

T2 - five-year clinical and economic results of a large randomized controlled trial

AU - Breeman, Suzanne

AU - Campbell, Marion

AU - Dakin, Helen

AU - Fiddian, Nick

AU - Fitzpatrick, Ray

AU - Grant, Adrian

AU - Gray, Alastair

AU - Johnston, Linda

AU - Maclennan, Graeme

AU - Morris, Richard

AU - Murray, David

AU - KAT Trial Group

PY - 2011/8/17

Y1 - 2011/8/17

N2 - Background: There is conflicting evidence regarding the merits of patellar resurfacing during total knee arthroplasty, as many of the previous randomized controlled trials have not been adequately powered.Methods: A pragmatic, multicenter, randomized controlled trial was initiated in 1999 in the United Kingdom. Within a partial factorial design, 1715 patients were randomly allocated to receive or not receive patellar resurfacing during total knee arthroplasty. The primary outcome measure was the Oxford Knee Score; secondary measures included the Short Form-12, the EuroQoL 5D, cost, cost-effectiveness, and the need for subsequent knee surgery.Results: The mean Oxford Knee Score was 35 points at five years postoperatively in both groups. There was no significant difference between the groups with respect to the mean Oxford Knee Score (difference, 0.59 point; 95% confidence interval, –0.58 to 1.76 points) or any other outcome measure at five years postoperatively. The outcome was not affected by whether the patella was domed or anatomic. There was no significant difference between the two groups with respect to the prevalence of knee-related readmission, of minor or intermediate reoperation, or of subsequent patella-related surgery. The total health care cost for the primary arthroplasty, subsequent monitoring, and any revision surgery did not differ significantly between the two groups.Conclusions: In the largest randomized controlled trial of patellar resurfacing reported to date, the functional outcome, reoperation rate, and total health care cost five years after primary total knee arthroplasty were not significantly affected by the addition of patellar resurfacing to the surgical procedure.Level of Evidence: Therapeutic Level I. See Instructions to Authors for a complete description of levels of evidence.

AB - Background: There is conflicting evidence regarding the merits of patellar resurfacing during total knee arthroplasty, as many of the previous randomized controlled trials have not been adequately powered.Methods: A pragmatic, multicenter, randomized controlled trial was initiated in 1999 in the United Kingdom. Within a partial factorial design, 1715 patients were randomly allocated to receive or not receive patellar resurfacing during total knee arthroplasty. The primary outcome measure was the Oxford Knee Score; secondary measures included the Short Form-12, the EuroQoL 5D, cost, cost-effectiveness, and the need for subsequent knee surgery.Results: The mean Oxford Knee Score was 35 points at five years postoperatively in both groups. There was no significant difference between the groups with respect to the mean Oxford Knee Score (difference, 0.59 point; 95% confidence interval, –0.58 to 1.76 points) or any other outcome measure at five years postoperatively. The outcome was not affected by whether the patella was domed or anatomic. There was no significant difference between the two groups with respect to the prevalence of knee-related readmission, of minor or intermediate reoperation, or of subsequent patella-related surgery. The total health care cost for the primary arthroplasty, subsequent monitoring, and any revision surgery did not differ significantly between the two groups.Conclusions: In the largest randomized controlled trial of patellar resurfacing reported to date, the functional outcome, reoperation rate, and total health care cost five years after primary total knee arthroplasty were not significantly affected by the addition of patellar resurfacing to the surgical procedure.Level of Evidence: Therapeutic Level I. See Instructions to Authors for a complete description of levels of evidence.

U2 - 10.2106/JBJS.J.00725

DO - 10.2106/JBJS.J.00725

M3 - Article

C2 - 22204002

VL - 93

SP - 1473

EP - 1481

JO - The Journal of Bone & Joint Surgery. American Volume

JF - The Journal of Bone & Joint Surgery. American Volume

SN - 0021-9355

IS - 16

ER -